Absorption and Metabolism of 4-hydroxyderricin and Xanthoangelol After Oral Administration of Angelica Keiskei (Ashitaba) Extract in Mice
Overview
Biophysics
Authors
Affiliations
To investigate the absorption and metabolism of 4-hydroxyderricin and xanthoangelol, we established an analytical method based on liquid chromatography-tandem mass spectrometry and measured these compounds in the plasma, urine, feces, liver, kidney, spleen, muscle and white adipose tissues of mice orally administered with Ashitaba extract (50-500mg/kg body weight). 4-Hydroxyderricin and xanthoangelol were quickly absorbed into the plasma, with time-to-maximum plasma concentrations of 2 and 0.5h for 4-hydroxyderricin and xanthoangelol, respectively. Although these compounds have similar structures, the total plasma concentration of 4-hydroxyderricin and its metabolites was approximately 4-fold greater than that of xanthoangelol and its metabolites at 24h. 4-Hydroxyderricin and xanthoangelol were mostly excreted in their aglycone forms and related metabolites (glucuronate and/or sulfate forms) in urine between 2 and 4h after oral administration of Ashitaba extract. On the other hand, these compounds were only excreted in their aglycone forms in feces. When tissue distribution of 4-hydroxyderricin and xanthoangelol was estimated 2h after administration of Ashitaba extract, both compounds were detected in all of the tissues assessed, mainly in their aglycone forms, except in the mesenteric adipose tissue. These results suggest that 4-hydroxyderricin and xanthoangelol are rapidly absorbed and distributed to various tissues.
Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283.
Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst K, Maciuk A EFSA J. 2024; 22(3):e8645.
PMID: 38469361 PMC: 10926279. DOI: 10.2903/j.efsa.2024.8645.
Rowhanirad S, Taherianfard M Brain Behav. 2023; 13(9):e3144.
PMID: 37403256 PMC: 10498084. DOI: 10.1002/brb3.3144.
Kweon M, Lee H, Park C, Choi Y, Ryu J Nutrients. 2019; 11(10).
PMID: 31658768 PMC: 6835314. DOI: 10.3390/nu11102419.
Zhang L, Jiang Y, Pang X, Hua P, Gao X, Li Q Molecules. 2019; 24(19).
PMID: 31554203 PMC: 6804174. DOI: 10.3390/molecules24193461.
4-Hydroxyderricin inhibits osteoclast formation and accelerates osteoblast differentiation.
Hagiwara H, Nakata K, Miyazaki H, Maehashi S, Komiyama Y, Aida R Cytotechnology. 2018; 71(1):15-22.
PMID: 30474804 PMC: 6368502. DOI: 10.1007/s10616-018-0236-2.